Neogen (NEOG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Sep, 2026Executive summary
Supplement corrects an error in Appendix B of the proxy statement regarding the Employee Stock Purchase Plan (ESPP) share reserve figure.
The correction updates the maximum number of shares authorized for issuance under the ESPP to 6,000,000.
No other changes have been made to the ESPP, proxy card, or other proposals.
Previously submitted votes on Proposal 5 remain valid; no further action is required unless a change is desired.
Voting matters and shareholder proposals
Proposal 5 seeks shareholder approval to increase the ESPP share authorization by 5,000,000 shares.
The Board recommends a vote FOR Proposal 5 and all other proposals.
The proxy card is unaffected by the correction, as it refers generally to the ESPP amendment.
Shareholder rights and capital structure
Shareholders may change or revoke their vote by submitting a new proxy, voting online or by phone, delivering written notice, or voting at the meeting.
The last vote submitted before the meeting will be counted.
Latest events from Neogen
- FY31 targets pair HSD-to-LDD growth with ~30% adjusted EBITDA margin and ~80% FCF conversion.NEOG
Investor Day 2026 - Core growth and margin gains lifted FY27 guidance as the Petrifilm transition advanced.NEOG
Q1 2027 - All proposals passed with high approval, including director elections and plan amendments.NEOG
AGM 2026 - Virtual annual meeting to vote on directors, compensation, auditor, and plan amendments.NEOG
Proxy filing - Improved growth, leadership changes, and enhanced ESG drive key proxy proposals for 2026.NEOG
Proxy filing - Q4 core growth accelerated, margins improved, and FY27 guidance signals continued momentum.NEOG
Q4 2026 - Integration progress and international growth position the business for margin expansion and recovery.NEOG
2024 Wells Fargo Healthcare Conference - Q2 FY26 delivered 2.9% core growth, margin expansion, and a raised FY26 outlook.NEOG
Q2 2026 - Q2 revenue hit $230M as integration advances, margin initiatives progress, and global growth accelerates.NEOG
Piper Sandler 36th Annual Healthcare Conference